The expression of FAM110A was elevated in most cancers, including BLCA, BRCA, CESC, CHOL, COAD, diffuse large B-cell lymphoma (DLBC), ESCA, GBM, HNSC, KIRC, KIRP, acute myeloid leukemia (LAML), lower grade glioma (LGG), LIHC, LUAD, LUSC, ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), PCPG, PRAD, READ, STAD, testicular germ cell tumors (TGCT), THCA, thymoma (THYM), UCEC, and uterine carcinosarcoma. This evidence concerns the gene FAM110A and uterine carcinosarcoma.